Loading…

Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents

Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular liquids 2021-03, Vol.325, p.115187-115187, Article 115187
Main Authors: Adam, Abdel Majid A., Saad, Hosam A., Alsuhaibani, Amnah M., Refat, Moamen S., Hegab, Mohamed S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763
cites cdi_FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763
container_end_page 115187
container_issue
container_start_page 115187
container_title Journal of molecular liquids
container_volume 325
creator Adam, Abdel Majid A.
Saad, Hosam A.
Alsuhaibani, Amnah M.
Refat, Moamen S.
Hegab, Mohamed S.
description Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic is of vital and pressing importance. The purpose of this study was to characterize the charge transfer (CT) complexation of AZM with iodine in four different solvents: CH2Cl2, CHCl3, CCl4, and C6H5Cl. AZM reacted with iodine at a 1:1 M ratio (AZM to I2) in the CHCl3 solvent and a 1:2 M ratio in the other three solvents, as evidenced by data obtained from an elemental analysis of the solid CT products and spectrophotometric titration and Job's continuous variation method for the soluble CT products. Data obtained from UV–visible and Raman spectroscopies indicated that AZM strongly interacted with iodine in the CH2Cl2, CCl4, and C6H5Cl solvents by a physically potent n→σ* interaction to produce a tri-iodide complex formulated as [AZM·I+]I3−. XRD and TEM analyses revealed that, in all solvents, the AZM-I2 complex possessed an amorphous structure composed of spherical particles ranging from 80 to 110 nm that tended to aggregate into clusters. The findings described in the present study will hopefully contribute to optimizing the treatment protocols for COVID-19. [Display omitted] •CT interaction between azithromycin and iodine was investigated.•Complex structures were characterized using several physicochemical techniques.•Striking color changes were observed in both soluble and solid forms.•This CT interaction occurred through the formation of a tri-iodide complex.
doi_str_mv 10.1016/j.molliq.2020.115187
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7764390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167732220374298</els_id><sourcerecordid>2475085988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763</originalsourceid><addsrcrecordid>eNp9UU1v1DAQtRCILoV_gJCPRSKLHSdOlgMSCl8rVSoH4Gq59qSZVWJvbWeX5TfxI3HZUuDCxSN53ps38x4hTzlbcsbly81y8uOI18uSlfmL17xt7pFFfkUhuJT3ySLDmqIRZXlCHsW4YYzVdcsekhMhxIpJIRbkRzfocAVFCtrFHgI1A0wYUzhQ31P9HdMQ_HQw6F7QNADVLuEl-oSGzhEs3fsw2j1aoMnTFECnXzDjg3d6h2GO1GIEHYGedRdf128Lvnq-pJ90SHT9inZ-2o7wTSf0ju6zGEVv0QFFl3l9XghcotGPu1zjY_Kg12OEJ7f1lHx5_-5z97E4v_iw7t6cF6aSIhUAom5lPt6WrALGrO4bmzvAuJYtA8HaFTBjQBtrStA9yLYEWWcHddM0UpyS18e52_lyAmuydtCj2gacdDgor1H923E4qCu_U5lcZWfzgLPbAcFfzxCTyp4aGEftwM9RlVVTs7ZetW2GVkeoCT7GAP2dDGfqJmi1Uceg1U3Q6hh0pj37e8U70u9k_9wA2agdQlDRIDgDFgOYpKzH_yv8BGChwBU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2475085988</pqid></control><display><type>article</type><title>Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents</title><source>ScienceDirect Freedom Collection</source><creator>Adam, Abdel Majid A. ; Saad, Hosam A. ; Alsuhaibani, Amnah M. ; Refat, Moamen S. ; Hegab, Mohamed S.</creator><creatorcontrib>Adam, Abdel Majid A. ; Saad, Hosam A. ; Alsuhaibani, Amnah M. ; Refat, Moamen S. ; Hegab, Mohamed S.</creatorcontrib><description>Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic is of vital and pressing importance. The purpose of this study was to characterize the charge transfer (CT) complexation of AZM with iodine in four different solvents: CH2Cl2, CHCl3, CCl4, and C6H5Cl. AZM reacted with iodine at a 1:1 M ratio (AZM to I2) in the CHCl3 solvent and a 1:2 M ratio in the other three solvents, as evidenced by data obtained from an elemental analysis of the solid CT products and spectrophotometric titration and Job's continuous variation method for the soluble CT products. Data obtained from UV–visible and Raman spectroscopies indicated that AZM strongly interacted with iodine in the CH2Cl2, CCl4, and C6H5Cl solvents by a physically potent n→σ* interaction to produce a tri-iodide complex formulated as [AZM·I+]I3−. XRD and TEM analyses revealed that, in all solvents, the AZM-I2 complex possessed an amorphous structure composed of spherical particles ranging from 80 to 110 nm that tended to aggregate into clusters. The findings described in the present study will hopefully contribute to optimizing the treatment protocols for COVID-19. [Display omitted] •CT interaction between azithromycin and iodine was investigated.•Complex structures were characterized using several physicochemical techniques.•Striking color changes were observed in both soluble and solid forms.•This CT interaction occurred through the formation of a tri-iodide complex.</description><identifier>ISSN: 0167-7322</identifier><identifier>EISSN: 1873-3166</identifier><identifier>DOI: 10.1016/j.molliq.2020.115187</identifier><identifier>PMID: 33390633</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Azithromycin ; Charge–transfer ; Iodine ; Solvent effect ; Tri–iodide ion</subject><ispartof>Journal of molecular liquids, 2021-03, Vol.325, p.115187-115187, Article 115187</ispartof><rights>2020 Elsevier B.V.</rights><rights>2020 Elsevier B.V. All rights reserved.</rights><rights>2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763</citedby><cites>FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33390633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adam, Abdel Majid A.</creatorcontrib><creatorcontrib>Saad, Hosam A.</creatorcontrib><creatorcontrib>Alsuhaibani, Amnah M.</creatorcontrib><creatorcontrib>Refat, Moamen S.</creatorcontrib><creatorcontrib>Hegab, Mohamed S.</creatorcontrib><title>Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents</title><title>Journal of molecular liquids</title><addtitle>J Mol Liq</addtitle><description>Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic is of vital and pressing importance. The purpose of this study was to characterize the charge transfer (CT) complexation of AZM with iodine in four different solvents: CH2Cl2, CHCl3, CCl4, and C6H5Cl. AZM reacted with iodine at a 1:1 M ratio (AZM to I2) in the CHCl3 solvent and a 1:2 M ratio in the other three solvents, as evidenced by data obtained from an elemental analysis of the solid CT products and spectrophotometric titration and Job's continuous variation method for the soluble CT products. Data obtained from UV–visible and Raman spectroscopies indicated that AZM strongly interacted with iodine in the CH2Cl2, CCl4, and C6H5Cl solvents by a physically potent n→σ* interaction to produce a tri-iodide complex formulated as [AZM·I+]I3−. XRD and TEM analyses revealed that, in all solvents, the AZM-I2 complex possessed an amorphous structure composed of spherical particles ranging from 80 to 110 nm that tended to aggregate into clusters. The findings described in the present study will hopefully contribute to optimizing the treatment protocols for COVID-19. [Display omitted] •CT interaction between azithromycin and iodine was investigated.•Complex structures were characterized using several physicochemical techniques.•Striking color changes were observed in both soluble and solid forms.•This CT interaction occurred through the formation of a tri-iodide complex.</description><subject>Azithromycin</subject><subject>Charge–transfer</subject><subject>Iodine</subject><subject>Solvent effect</subject><subject>Tri–iodide ion</subject><issn>0167-7322</issn><issn>1873-3166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAQtRCILoV_gJCPRSKLHSdOlgMSCl8rVSoH4Gq59qSZVWJvbWeX5TfxI3HZUuDCxSN53ps38x4hTzlbcsbly81y8uOI18uSlfmL17xt7pFFfkUhuJT3ySLDmqIRZXlCHsW4YYzVdcsekhMhxIpJIRbkRzfocAVFCtrFHgI1A0wYUzhQ31P9HdMQ_HQw6F7QNADVLuEl-oSGzhEs3fsw2j1aoMnTFECnXzDjg3d6h2GO1GIEHYGedRdf128Lvnq-pJ90SHT9inZ-2o7wTSf0ju6zGEVv0QFFl3l9XghcotGPu1zjY_Kg12OEJ7f1lHx5_-5z97E4v_iw7t6cF6aSIhUAom5lPt6WrALGrO4bmzvAuJYtA8HaFTBjQBtrStA9yLYEWWcHddM0UpyS18e52_lyAmuydtCj2gacdDgor1H923E4qCu_U5lcZWfzgLPbAcFfzxCTyp4aGEftwM9RlVVTs7ZetW2GVkeoCT7GAP2dDGfqJmi1Uceg1U3Q6hh0pj37e8U70u9k_9wA2agdQlDRIDgDFgOYpKzH_yv8BGChwBU</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Adam, Abdel Majid A.</creator><creator>Saad, Hosam A.</creator><creator>Alsuhaibani, Amnah M.</creator><creator>Refat, Moamen S.</creator><creator>Hegab, Mohamed S.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210301</creationdate><title>Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents</title><author>Adam, Abdel Majid A. ; Saad, Hosam A. ; Alsuhaibani, Amnah M. ; Refat, Moamen S. ; Hegab, Mohamed S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Azithromycin</topic><topic>Charge–transfer</topic><topic>Iodine</topic><topic>Solvent effect</topic><topic>Tri–iodide ion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adam, Abdel Majid A.</creatorcontrib><creatorcontrib>Saad, Hosam A.</creatorcontrib><creatorcontrib>Alsuhaibani, Amnah M.</creatorcontrib><creatorcontrib>Refat, Moamen S.</creatorcontrib><creatorcontrib>Hegab, Mohamed S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular liquids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adam, Abdel Majid A.</au><au>Saad, Hosam A.</au><au>Alsuhaibani, Amnah M.</au><au>Refat, Moamen S.</au><au>Hegab, Mohamed S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents</atitle><jtitle>Journal of molecular liquids</jtitle><addtitle>J Mol Liq</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>325</volume><spage>115187</spage><epage>115187</epage><pages>115187-115187</pages><artnum>115187</artnum><issn>0167-7322</issn><eissn>1873-3166</eissn><abstract>Around the world, the antibiotic azithromycin (AZM) is currently being used to treat the coronavirus disease (COVID-19) in conjunction with hydroxychloroquine or chloroquine. Investigating the chemical and physical properties of compounds used alone or in combination to combat the COVID-19 pandemic is of vital and pressing importance. The purpose of this study was to characterize the charge transfer (CT) complexation of AZM with iodine in four different solvents: CH2Cl2, CHCl3, CCl4, and C6H5Cl. AZM reacted with iodine at a 1:1 M ratio (AZM to I2) in the CHCl3 solvent and a 1:2 M ratio in the other three solvents, as evidenced by data obtained from an elemental analysis of the solid CT products and spectrophotometric titration and Job's continuous variation method for the soluble CT products. Data obtained from UV–visible and Raman spectroscopies indicated that AZM strongly interacted with iodine in the CH2Cl2, CCl4, and C6H5Cl solvents by a physically potent n→σ* interaction to produce a tri-iodide complex formulated as [AZM·I+]I3−. XRD and TEM analyses revealed that, in all solvents, the AZM-I2 complex possessed an amorphous structure composed of spherical particles ranging from 80 to 110 nm that tended to aggregate into clusters. The findings described in the present study will hopefully contribute to optimizing the treatment protocols for COVID-19. [Display omitted] •CT interaction between azithromycin and iodine was investigated.•Complex structures were characterized using several physicochemical techniques.•Striking color changes were observed in both soluble and solid forms.•This CT interaction occurred through the formation of a tri-iodide complex.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33390633</pmid><doi>10.1016/j.molliq.2020.115187</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-7322
ispartof Journal of molecular liquids, 2021-03, Vol.325, p.115187-115187, Article 115187
issn 0167-7322
1873-3166
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7764390
source ScienceDirect Freedom Collection
subjects Azithromycin
Charge–transfer
Iodine
Solvent effect
Tri–iodide ion
title Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T03%3A27%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Charge-transfer%20chemistry%20of%20azithromycin,%20the%20antibiotic%20used%20worldwide%20to%20treat%20the%20coronavirus%20disease%20(COVID-19).%20Part%20I:%20Complexation%20with%20iodine%20in%20different%20solvents&rft.jtitle=Journal%20of%20molecular%20liquids&rft.au=Adam,%20Abdel%20Majid%20A.&rft.date=2021-03-01&rft.volume=325&rft.spage=115187&rft.epage=115187&rft.pages=115187-115187&rft.artnum=115187&rft.issn=0167-7322&rft.eissn=1873-3166&rft_id=info:doi/10.1016/j.molliq.2020.115187&rft_dat=%3Cproquest_pubme%3E2475085988%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c463t-ee3586016d204e00daf7d463e01a680e3089e0cceacdc2eafe682e65518a77763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2475085988&rft_id=info:pmid/33390633&rfr_iscdi=true